Awareness Week

Crohn’s and Colitis Awareness Week

A week that starts on December 1 every year. Next: in 21 days

What it’s about

Crohn’s and Colitis Awareness Week is a week-long observance held during December to raise understanding of Crohn’s disease and ulcerative colitis—two chronic conditions that affect the digestive system. The week highlights the realities of living with inflammatory bowel disease (IBD), including symptoms and challenges that may not always be visible to others.

It is also an opportunity to encourage compassion, share reliable information, and support people affected by Crohn’s and colitis, along with their families and caregivers. Through conversations, educational efforts, and community support, the observance helps reduce stigma and reminds everyone that greater awareness can lead to earlier understanding, stronger support, and improved quality of life.

A little history

Crohn’s and Colitis Awareness Week is a week-long observance held during December to increase public understanding of inflammatory bowel disease (IBD), particularly Crohn’s disease and ulcerative colitis. These chronic conditions affect the digestive tract and can involve pain, fatigue, urgent bowel movements, and other symptoms that are not always visible to others. The observance provides an annual opportunity to explain the medical and personal realities of IBD while correcting the misconception that these illnesses are simply minor digestive problems.

Its historical background is connected to the development of modern knowledge about IBD and to the growth of patient advocacy. Crohn’s disease was identified and described in the early twentieth century by physician Burrill B. Crohn and his colleagues, while ulcerative colitis had been recognized by physicians earlier. Over time, research, specialist care, and the experiences of patients and families helped establish IBD as a significant chronic-health issue requiring long-term treatment and support. Organizations devoted to Crohn’s disease and ulcerative colitis subsequently played an important role in funding research, educating the public, and encouraging people with symptoms to seek medical advice.

As awareness efforts evolved, the focus broadened beyond disease definitions and treatment information. Campaigns increasingly addressed the emotional and social effects of IBD, including stigma, disrupted education or employment, mental-health challenges, and the difficulty of living with symptoms that may be invisible. The week also highlights continuing research into the causes of IBD, improvements in diagnosis and medication, and the importance of individualized care. Public education commonly uses personal stories, informational campaigns, community events, and fundraising to connect medical knowledge with lived experience.

Culturally, Crohn’s and Colitis Awareness Week gives patients and families a recognized period in which to speak openly about conditions that are often considered embarrassing or difficult to discuss. It encourages empathy in schools, workplaces, and communities and reinforces that people with IBD may require flexibility, access to restrooms, and understanding even when they appear healthy. By bringing together patients, caregivers, clinicians, researchers, and advocates during a week in December, the observance helps turn private experiences into a broader conversation about chronic illness, inclusion, and the need for continued medical progress.

Timeline

  1. 1859

    English physician Samuel Wilks published an early clinical description of ulcerative colitis, distinguishing it from other inflammatory diseases of the bowel.

  2. 1932

    Burrill B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer published their landmark description of “regional ileitis,” the condition later known as Crohn’s disease.

  3. 1967

    The National Foundation for Ileitis and Colitis was founded; it later became the Crohn’s & Colitis Foundation, a major U.S. nonprofit supporting inflammatory bowel disease research and advocacy.

  4. 1998

    The U.S. Food and Drug Administration approved infliximab (Remicade) for treatment of moderate-to-severe Crohn’s disease, marking a major biologic-therapy milestone.

  5. 2005

    The U.S. Food and Drug Administration approved infliximab for adults with moderate-to-severe ulcerative colitis, extending biologic treatment to this form of inflammatory bowel disease.

Other weeks starting December 1

Weeks in December

More like this

Just for fun

All of January

Adopt a Rescued Bird Month

January is a time for new beginnings, and what better way to embrace the spirit of renewal than by celebrating Adopt a Rescued Bird Month? This special observance shines a…

Just for fun All month United States, Canada +1
Awareness

January 1

Apple Gifting Day

Apple Gifting Day, celebrated on January 1st, invites individuals and families to begin the new year with a sweet and wholesome tradition that symbolizes health, friendship, and…

Awareness
Awareness

All of January

Be Kind To Food Servers Month

Be Kind to Food Servers Month, celebrated on January 1, is a heartwarming reminder to appreciate the hard work and dedication of those who serve us our meals. As we usher in the…

Awareness All month United States, Canada